Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Vaxess Technologies
company
About
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.50M
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Dec 18, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery. Vaxess strives to not only lower the cost of vaccine distribution, but also increase access to life-saving products for people around the world.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
8
$8.16M
Vaxess Technologies has raised a total of
$8.16M
in funding over 2 rounds. Their latest funding was raised on
Sep 1, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 1, 2020 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Oct 9, 2018 | Grant | $650K | 1 |
National Science Foundation
|
— | Detail |
| Dec 14, 2017 | Grant | $1.50M | 1 | — | — | Detail |
| Sep 20, 2016 | Grant | $1.40M | 1 |
National Science Foundation
|
— | Detail |
| Apr 6, 2015 | Grant | $220K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
4
3
Vaxess Technologies is funded by 3 investors.
National Science Foundation
and Norwich Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Norwich Ventures
|
Yes | Series A |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
